SeLux Diagnostics: Funding, Investors & Team (Oct 2026)
SeLux Diagnostics is a designer of the Next-Generation Phenotyping (NGP) stage that empowers customized anti-toxin treatments for patients. The organization was established in 2014 and is situated in Charlestown, MA.
SeLux Diagnostics has raised $52.6M across 3 funding rounds on record, the most recent a Grant of $8.0M announced in Jul 2022.
That round is in line with the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SeLux Diagnostics Company Profile and Key Stats
Latest funding round on record: Jul 2022.
SeLux Diagnostics Funding Rounds
SeLux Diagnostics raised $14.6M in an undisclosed round announced in Jun 2021.
1 years later, a Debt Financing of $30.0M was announced in Jun 2022.
1 month later, a Grant of $8.0M was announced in Jul 2022.
SeLux Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
SeLux Diagnostics Funding Compared to Other Biotechnology Startups
SeLux Diagnostics' latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SeLux Diagnostics in Biotechnology and Charlestown
Companies Similar to SeLux Diagnostics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
SeLux Diagnostics Funding FAQs
What does SeLux Diagnostics do?
SeLux Diagnostics is a designer of the Next-Generation Phenotyping (NGP) stage that empowers customized anti-toxin treatments for patients. The organization was established in 2014 and is situated in Charlestown, MA.
How much funding has SeLux Diagnostics raised?
SeLux Diagnostics has raised $52.6M across 3 rounds on record. The most recent is a Grant of $8.0M announced in Jul 2022.
When did SeLux Diagnostics last raise funding?
SeLux Diagnostics' most recent funding round on record is a Grant of $8.0M, announced in Jul 2022.
Who founded SeLux Diagnostics?
FundedIQ lists Aleksandar Vacic (Founder) at SeLux Diagnostics.
Who is the CEO of SeLux Diagnostics?
Steve Lufkin is listed as CEO at SeLux Diagnostics.
Where is SeLux Diagnostics headquartered?
SeLux Diagnostics is based in Charlestown, Massachusetts, United States.
How many employees does SeLux Diagnostics have?
SeLux Diagnostics is in the 51-100 employee band.
How does SeLux Diagnostics' funding compare to other Biotechnology startups?
SeLux Diagnostics' latest round of $8.0M is in line with the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SeLux Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SeLux Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.